Distribution of β-lactamase genes among carbapenem-resistant Klebsiella pneumoniae strains isolated from patients in Turkey

Annals of Laboratory Medicine

Volumn 35, Issue 6, 2015, Pages 595-601

  Iraz, Meryem ^a   Düzgün, Azer Özad ^b   Sandalli, Cemal ^c   Doymaz, Mehmet Ziya ^a   Akkoyunlu, Yasemin ^a   Saral, Ayşegül ^d   Peleg, Anton Y ^e,f   Özgümüş, Osman Birol ^c   Beriş, Fatih Şaban ^c   Karaoʇlu, Hakan ^c   Çiçek, Ayşegül Çopur ^c  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b GUMUSHANE UNIVERSITY   (Turkey)

^c RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^d ARTVIN CORUH UNIVERSITY   (Turkey)

^e MONASH UNIVERSITY   (Australia)

^f ALFRED HOSPITAL   (Australia)

Author keywords

BlaTEM 166; Colistin; K. pneumoniae; NDM 1; OXA 48

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE;

ANTIBIOTIC RESISTANCE; CHEMISTRY; DNA SEQUENCE; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION; TURKEY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; TURKEY;

EID: 84942251829     PISSN: 22343806     EISSN: 22343814     Source Type: Journal    
DOI: 10.3343/alm.2015.35.6.595     Document Type: Article

References (30)

1. Pitout JD. Recent changes in the epidemiology and management of extended-spectrum β-lactamase-producing Enterobacteriaceae. F1000 Med Rep 2009;1. pii:84.
2. Jadhav S, Misra R, Gandham N, Ujagare M, Ghosh P, Kalpana A, et al. Increasing incidence of multidrug resistance Klebsiella pneumoniae infections in hospital and community settings. Int J Microbiol Res 2012; 4:253-7.
3. Bradford PA, Urban C, Mariano N, Projan SJ, Rahal JJ, Bush K. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997;4: 563-9.
4. Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of blaACT-1 β-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoE. Antimicrob Agents Chemother 2006;50:3396-406.
5. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med 2012;18:263-72.
6. Giani T, Pini B, Arena F, Conte V, Bracco S, Migliavacca R, et al. Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill 2013;18. pii:20489.
7. Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 2004;48:15-22.
8. Aktaş Z, Kayacan CB, Schneider I, Can B, Midilli K, Bauernfeind A. Carbapenem-hydrolyzing oxacillinase, OXA-48, persists in Klebsiella pneumonia in Istanbul, Turkey. Chemotherapy 2008;54:101-6.
9. Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumonia isolates in Istanbul, Turkey. Antimicrob Agents Chemother 2008;52: 2950-4.
10. Gülmez D, Woodford N, Palepou MF, Mushtaq S, Metan G, Yakupogullari Y, et al. Carbapenem-resistant Escherichia coli and Klebsiella pneumonia isolates from Turkey with OXA-48-like carbapenemases and outer membrane protein loss. Int J Antimicrob Agents 2008;31:523-6.
11. Poirel L, Ozdamar M, Ocampo-Sosa AA, Türkoʇlu S, Ozer UG, Nordmann P. NDM-1- producing Klebsiella pneumoniae now in Turkey. Antimicrob Agents Chemother 2012;56:2784-5.
12. Copur Cicek A, Ozad Duzgun A, Saral A, Sandalli C. Determination of a novel integron-located variant (blaOXA-320) of Class D β-lactamase in Proteus mirabilis. J Basic Microbiol 2014;54:1030-5.
13. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. M100-S23. Wayne, PA: Clinical and Laboratory Standards Institute, 2013.
14. Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-402.
15. Copur Cicek A, Saral A, Iraz M, Ceylan A, Duzgun AO, Peleg AY, et al. OXA- and GES-type β-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect 2014;20:410-5.
16. Copur Cicek A, Saral A, Ozad Duzgun A, Yasar E, Cizmeci Z, Ozlem Balci P, et al. Nationwidestudy of Escherichia coli producing extended-spectrum β-lactamases TEM, SHV and CTX-M in Turkey. J Antibiot 2013; 66:647-50.
17. Andriamanantena TS, Ratsima E, Rakotonirina HC, Randrianirina F, Ramparany L, Carod JF, et al. Dissemination of multidrug resistant Acinetobacter baumannii in various hospitals of Antananarivo Madagascar. Ann Clin Microbiol Antimicrob 2010;9:17.
18. Podschun R and Ullman U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev 1998;11:589-603.
19. Poirel L, Pitout JD, Nordmann P. Carbapenemases: molecular diversity and clinical consequences. Future Microbiol 2007;2:501-12.
20. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, et al. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
21. Johnson AP and Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-β-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013;62:499-513.
22. Seija V, Medina Presentado JC, Bado I, Papa Ezdra R, Batista N, Gutierrez C, et al. Sepsis caused by New Delhi metallo-β-lactamase (blaNDM-1) and qnrD-producing Morganella morganii, treated successfully with fosfomycin and meropenem: case report and literature review. Int J Infect Dis 2015;30:20-6.
23. Nordmann P, Poirel L, Walsh TR, Livermore DM. The emerging NDM carbapenemases. Trends Microbiol 2011;19:588-95.
24. Kim SY, Rhee JY, Shin SY, Ko KS. Characteristics of community-onset NDM-1-producing Klebsiella pneumonia isolates. J Med Microbiol 2014;63:86-9.
25. Rasheed JK, Kitchel B, Zhu W, Anderson KF, Clark NC, Ferraro MJ, et al. New Delhi metallo-β-lactamase-producing Enterobacteriaceae, United States. Emerg Infect Dis 2013;19:870-8.
26. Evans B and Amyes SG. OXA β-lactamases. Clin Microbiol Rev 2014; 27:241-63.
27. Alp E, Perçin D, Colakoʇlu S, Durmaz S, Kürkcü CA, Ekincioʇlu P, et al. Molecular characterization of carbapenem-resistant Klebsiella pneumoniae in a tertiary university hospital in Turkey. J Hosp Infect 2013;84: 178-80.
28. Pitout JD, Nordmann P, Laupland KB, Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J Antimicrob Chemother 2005;56: 52-9.
29. Gür D, Gülay Z, Akan OA, Aktaş Z, Kayacan CB, Cakici O, et al. Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study. Mikrobiyol Bul 2008;42:537-44.
30. Onnberg A, Mölling P, Zimmermann J, Söderquist B. Molecular and phenotypic characterization of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum β-lactamases with focus on CTX-M in a low-endemic area in Sweden. APMIS 2011;119:287-95.